Literature DB >> 9250682

A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis.

D Israeli1, E Tessler, Y Haupt, A Elkeles, S Wilder, R Amson, A Telerman, M Oren.   

Abstract

The biological effects of the p53 tumor suppressor protein are elicited, at least in part, through sequence-specific transactivation of a battery of target genes. The differential display method was employed towards identifying additional p53 target genes, with emphasis on genes whose induction may contribute to p53-mediated apoptosis. We report here the cloning of a novel p53-inducible gene, designated PAG608. PAG608 transcripts are induced by DNA damage in a p53-dependent manner. PAG608 encodes a nuclear zinc finger protein, which appears to localize preferentially to nucleoli when expressed at moderate levels in transfected cells. Transient overexpression of PAG608 in human tumor-derived cells leads to distinctive changes in nuclear morphology, and can promote apoptosis. Together with additional p53 target genes, PAG608 may therefore play a role in mediating the biological activities of p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250682      PMCID: PMC1170064          DOI: 10.1093/emboj/16.14.4384

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  p53-mediated apoptosis in HeLa cells can be overcome by excess pRB.

Authors:  Y Haupt; S Rowan; M Oren
Journal:  Oncogene       Date:  1995-04-20       Impact factor: 9.867

Review 3.  Biochemical properties and biological effects of p53.

Authors:  R Haffner; M Oren
Journal:  Curr Opin Genet Dev       Date:  1995-02       Impact factor: 5.578

4.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

5.  Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product.

Authors:  A H Cavanaugh; W M Hempel; L J Taylor; V Rogalsky; G Todorov; L I Rothblum
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

6.  p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.

Authors:  C Caelles; A Helmberg; M Karin
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

7.  Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.

Authors:  M Selvakumaran; H K Lin; T Miyashita; H G Wang; S Krajewski; J C Reed; B Hoffman; D Liebermann
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

8.  Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.

Authors:  M L Smith; I T Chen; Q Zhan; I Bae; C Y Chen; T M Gilmer; M B Kastan; P M O'Connor; A J Fornace
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

9.  Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.

Authors:  A Zauberman; A Lupo; M Oren
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

Authors:  K Okamoto; D Beach
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  38 in total

1.  ei24, a p53 response gene involved in growth suppression and apoptosis.

Authors:  Z Gu; C Flemington; T Chittenden; G P Zambetti
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Disruption of a locus encoding a nucleolar zinc finger protein decreases tachyzoite-to-bradyzoite differentiation in Toxoplasma gondii.

Authors:  Padmini Vanchinathan; Jeremy L Brewer; Omar S Harb; John C Boothroyd; Upinder Singh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  p21 delays tumor onset by preservation of chromosomal stability.

Authors:  Juan A Barboza; Geng Liu; Zhenlin Ju; Adel K El-Naggar; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

4.  The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element.

Authors:  Anna Vilborg; Jacob A Glahder; Margareta T Wilhelm; Cinzia Bersani; Martin Corcoran; Salah Mahmoudi; Maiken Rosenstierne; Dan Grandér; Marianne Farnebo; Bodil Norrild; Klas G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-01       Impact factor: 11.205

5.  The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Authors:  C Venot; M Maratrat; C Dureuil; E Conseiller; L Bracco; L Debussche
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

6.  The Mdm2 oncoprotein interacts with the cell fate regulator Numb.

Authors:  T Juven-Gershon; O Shifman; T Unger; A Elkeles; Y Haupt; M Oren
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

Review 8.  The p53 target Wig-1: a regulator of mRNA stability and stem cell fate?

Authors:  A Vilborg; C Bersani; M T Wilhelm; K G Wiman
Journal:  Cell Death Differ       Date:  2011-03-11       Impact factor: 15.828

9.  JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity.

Authors:  Mingli Yang; Song Wu; Xuekun Su; W Stratford May
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

Review 10.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.